Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Queensland Health
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Teva
Healthtrust
Chinese Patent Office
Citi

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089654

« Back to Dashboard

NDA 089654 describes PRELONE, which is a drug marketed by Muro and Teva and is included in two NDAs. It is available from two suppliers. Additional details are available on the PRELONE profile page.

The generic ingredient in PRELONE is prednisolone. There are eighty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the prednisolone profile page.
Summary for 089654
Tradename:PRELONE
Applicant:Muro
Ingredient:prednisolone
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 089654

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SYRUP;ORALStrength5MG/5ML
Approval Date:Jan 17, 1989TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
US Army
Teva
Mallinckrodt
Farmers Insurance
Healthtrust
Accenture
Chubb
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.